HealthResJ, health, medicine, nursing, research https://ejournals.epublishing.ekt.gr/index.php/HealthResJ/sitemap

Acute kidney injury. the need for renal replacement therapy and complications during the application

PDF
DOI: https://doi.org/10.12681/healthresj.20250
Keywords:
Acute Kidney Injury (AKI) renal replacement therapy complications acids events filter span anticoagulation.
Katerina Karpathiou
RN, MSc, National Primary Health Care Network, Pagrati, Athens
Dimitris Panagidis
RN, MSc, PhD(c), Intensive Care Unit, General Hospital of Athens ‘’Evagelismos’’
Olga Kadda
RN, PhD, Cardiological Intensive Care Unit, Onassis Cardiac Surgery Centre
Helen Dokoutsidou
Assistant Professor, Faculty of Nursing, Technological Educational Institute of Athens, Greece
Christine Routsi
Professor of Critical Care Medicine, National and Kapodistrian University of Athens
Serafim Nanas
Professor of Critical Care Medicine, National and Kapodistrian University of Athens
Abstract

Introduction: Acute kidney  injury (AKI) is a  very common complication of critically ill patients in ICU. It  is  associated  with significantly increased morbidity and mortality. Renal replacement is a treatment with a lot of complications.

Aim: The  aim of  the present  study  was  to  observe the incidence of  AKI, the need for treatment with continuous renal replacement and the problems during the  therapy.

Material and Methods: This  is  an  observational  study. The study sample were patients admitted to the ICU of General  hospital ‘’Evagelismos’’. AKI, was defined according to the  RIFLE criteria. For quantitative variables analysis was used the test of independence through '' t-test (Independent Samples T-Test) '', while the quality was analyzed by X2 test of independence. The analysis was performed with SPSS 19.0 statistical package.

Results: Of the 192 study patients, 28% had AKI and the 17% received renal replacement therapy. AKI is associated with increased mortality which increases as increases the severity. The most commonly problems of treatment were:  hypothermia to 57.5%, hypotension and clotting filters in 54.5% and 51.5%, respectively. Factor that affect early clotting of the extracorporeal circulation, is  the use of heparin versus citrate as anticoagulation.

Conclusions: AKI  is  associated with severe  mortality which increases as increases the severe  of  AKI  stage , respectively. Factor that is associated with higher rates of unsuccessful completion of treatment, is the choice  of  anticoagulation  strategy.

Article Details
  • Section
  • Research Articles

A) OPEN ACCESS POLICY

The journal "Health and Research Journal", follows an open access policy both for submission and accessing of articles.

Specifically the journal:

1. Claims no financial or any other gain from the author or authors of an article, neither for submission to the journal for publication, nor for revision and modification when peer reviewed.

2. Claims no financial or any other gain by articles' authors or by readers of the journal, for reading or downloading any article.

3. Reserves the right for the content and format of the printed article, not to be altered and to be used freely, preserving the form, the logo, the layout and the text as it is, a true copy of the file provided by the journal, with free access. (See also section C. Copyright Policy)

[The aforementioned apply equally for everyone and there is not any differentiation, restriction or other specific condition]

You can also ask more on the subject, from the editorial team of the journal, by sending mail to the journal. 

B) SELF-ARCHIVING POLICY

The journal "Health and Research journal", allows self-archiving of articles by the author or authors, under the following terms.

The journal allows:

1. The free self-archiving from the author, of a pre-printed article, at any stage of preparation it is, without limitations. As pre-printed, we consider the work that the author has not submitted yet to the journal and that certainly has not yet been peer reviewed.

2. The free self-archiving from the author, of the final, pre-printed article, that has been corrected and reviewed from the journal, with the expressed obligation to indicate that the article will be published by the journal "Health and Research Journal" and that it has been reviewed (or it is currently reviewed) by the journal's peer review process.

3. The free self-archiving from the author, of the final, printed article that has been published in the journal ""Health and Research Journal" with the expressed obligation to use only the printed pdf file of the journal (exact copy), that has the same logo, format and layout, as it is shared freely by the journal.

For more information on self-archiving policy, please contact the following link: OASIS (Open Access Scholarly Information Sourcebook)

You can also ask more on the subject, from the editorial team of the journal, by sending mail to journal.

C) COPYRIGHT POLICY

The journal "Health and Research Journal" reserves the rights for copyright of the content of the website and also the copyright of the articles published.

Specifically:

1. Does not allow any reproduction of part or whole of the content of the journal's website, if the original source is not explicitly stated.

2. Does not allow the usage, by third party, of journal's direct links to the pdf files (printed articles), if the original source is not explicitly stated (necessarily the name of the journal and optionally: year, volume, issue, pages).

3. All the members of the editorial board accept and comply with the national and international laws regarding copyrighted material, plagiarism and text-piracy, both for the content of the journal's website, as for the content of the published articles.

You can also ask more on the subject, from the editorial team of the journal, by sending mail to the journal.

D) PLAGIARISM POLICY

The journal "Health and Research Journal", reserves the right for detecting plagiarism, including duplicate publication of the author’s own work, in whole or in part without proper citation, either with the use of special software or manually, at any stage before publication. For published articles by the journal, originality may also be checked after specific private complaint.

In case of plagiarism detection:

1. If the percentage of the manuscript's plagiarism is below 26%, the journal will contact and inform the author, asking for further revision and resubmission.

2. If the percentage of the manuscript's plagiarism is over 25%, the journal will contact and inform the author about the rejection of the article, without editorial review. Author is then advised to fully revise the manuscript before its new sumbission.

Downloads
Download data is not yet available.
References
Ostermann M, Chang R and The Riyadh ICU Program Users Group. “Correlation between the AKI Classification and Outcome. [On-line]. 20 Nov 2008. [10]. Διαθέσιμο από:e http://ccforum.com/content/12/6/R144. [Πρόσβαση: 22 Dec 2016]
Kellum J. Acute kidney injury. Crit Care Med 2008; 36(4):141 – 145.
Kokkoris S,Grapsa E, Nanas S. Acute kidney injury and novel markers of renal function in adult intensive care unit patients. Archives of Hellenic Medicine 2012; 29(5):550-561.
Bellomo R, Kellum J, Ronco C. Acute kidney injury. Lancet 2012; 380: 756–66
Bagshaw, Sean M et al. “Early Acute Kidney Injury and Sepsis: A Multicentre Evaluation. [On-line]. 10 Apr 2008. [9]. Διαθέσιμο από:<http://ccforum.com/content/12/2/R47> . [Πρόσβαση: 22 Dec 2016]
Piccini P, Cruz D N, Gramatikopolo S, Garzotto F, Santo M D, Rocco M et al. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol 2011;77:1072–83.
Clec’h Chr, Gonzalez F, Lautrette A, Nguile – Makao M, Garrouste – Orgeas M, Jamali S et al. “Multiple-Center Evaluation of Mortality Associated with Acute Kidney Injury in Critically Ill Patients: A Competing Risks Analysis. [On-line]. 17 May 2011. [9]. Διαθέσιμο από: http://ccforum.com/content/15/3/R128”. [Πρόσβαση: 22 Dec 2016]
Palevsky M, Kathleen D, Brophy P, Chawla L, Parikh C. KDOQI US Commentary on the 2012 KDIGO Clinical PracticeGuideline for Acute Kidney Injury. Am J Kidney Dis 2013;61(5):649-672
Official Journal of the International Society of Nephrology .Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. [On-line]. March 2012. [141]. Διαθέσιμο από: http://www.kidney-international.org/ . [Πρόσβαση: 22 Dec 2016]
Kellum J, Bellomo R, Ronco C. The renal replacement therapy. Oxford University Press Inc . USA. 2010
Shigehiko U, Bellomo R, Morimatsu H, Morgera S, Schetz M,Tan I et al. Continuous renal replacement therapy: A worldwide practice survey The Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Intensive Care Med 2007; 33:1563–1570
Knaus W, Douglas P, Draper E, Zimmerman J, Bergner M, Bastos P et al. Clinical investigations in critical care,The APACHE III Prognostic System, Risk Prediction of Hospital Mortality for Critically III Hospitalized Adults. Chest 1991; 100:1619 -36
Bouch DC, Thompson JP. Severity scoring systems in the critically ill. British Journal of Anaesthesia 2008;8(5):181 – 185.
Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009; 24: 129–140.
RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627–1638.
VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7–20.
Barenbrock M, Hausberg M, Matzkies F, de la Motte S, Schaefer RM. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 2000; 58: 1751–1757.
Bassi E, Ferreira CB, Macedo E, Malbouisson LM. Recurrent Clotting of Dialysis Filter Associated With Hypertriglyceridemia Induced by Propofol. Am J Kidney Dis 2014;63(5):860-861
Kazory A, Clapp WL, Ejaz A, Ross E. Shortened hemofilter survival time due to lipid infusion in continuous renal replacement therapy. Nephron Clin Pract 2008;108(1):c5-c9.
Saha S, Shah P, Gibbs J, Collins J.“Effect of Total Parenteral Nutrition on the Duration of Haemofilter Circuit. [On-line]. 11 March 2011 .[3]. Διαθέσιμο από: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061740/. [Πρόσβαση:22 Dec 2016]
Dunn WJ, Sriram S. Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables. Crit Care Resusc 2014 Sep;16(3):225-31.
Zhang Z, Ni H, Lu B. Variables Associated with Circuit Life Span in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. A Prospective Observational Study. ASAIO J 2012;58(1):46-50.
Schilder L, Nurmohamed S, Bosch F, Purmer I, Den Boer S, Kleppe C et al. “Citrate Anticoagulation versus Systemic Heparinisation in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Multi-Center Randomized Clinical Trial. [On-line]. 16 August 2014. [9]. Διαθέσιμο από¨: http://ccforum.com/content/18/4/472. [ Πρόσβαση: 22 Dec 2016]
Rolando Cl, Macedo Ε, Soroko S, YeonWon Kim, Glenn M. Chertow J et al. Anticoagulation, Delivered Dose and Outcomes in CRRT: the Program to Improve Care in Acute Renal Disease (PICARD) 2014 ; 18(3): 641–649
Stucker F, Ponte B, Tataw J, Martin P, Wozniak H, Pugin J et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. [On-line].18 March 2015. [20]. Διαθέσιμο από:< https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364313/>. [ Πρόσβαση: 22 Dec 2016]
Crosswell A, Brain MJ, Roodenburg O. Vascular access site influences circuit life in continuous renal replacement therapy. Crit Care Resusc 2014;16(2):127-30.
Dugue A, Levesque S, Fischer M, Souweine B, Mira J, Megarbane B et al. Vascular Access Sites for Acute Renal Replacement in Intensive Care Units. Clin J Am Soc Nephrol 2012; 7: 70–77.
Parienti J, Megarbane B, Fischer M, Lautrette A, Gazui N, Marin N et al. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med 2010; 38: 1118–1125.
Morgan D, Ho K, Murray C, Davies H and Louw J. A Randomized Trial of Catheters of Different Lengths to Achieve Right Atrium Versus Superior Vena Cava Placement for Continuous Renal Replacement Therapy. Am J Kidney Dis 2012;60(2):272-279.
Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26: 232–239.
Rickard C, Couchman B, Hughes M, Mc Grail M. Preventing hypothermia during continuous veno-venous haemodiafiltration: a randomized controlled trial. Journal of Advanced Nursing 2004; 47(4):393-400.
Santiago M, López-Herce J, Urbano J, Solana M, Castillo J, Ballestero Y et al. Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study. [On-line]. 23 Nov 2009. [11]. Διαθέσιμο από: http://ccforum.com/content/13/6/R184. [ Πρόσβαση: 22 Dec 2016].
Most read articles by the same author(s)